NO970036L - Nytt oralt, farmasöytisk preparat inneholdende magnesiumsalt av omeprazol - Google Patents
Nytt oralt, farmasöytisk preparat inneholdende magnesiumsalt av omeprazolInfo
- Publication number
- NO970036L NO970036L NO970036A NO970036A NO970036L NO 970036 L NO970036 L NO 970036L NO 970036 A NO970036 A NO 970036A NO 970036 A NO970036 A NO 970036A NO 970036 L NO970036 L NO 970036L
- Authority
- NO
- Norway
- Prior art keywords
- omeprazole
- magnesium salt
- oral pharmaceutical
- pharmaceutical preparation
- preparation containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9400679 | 1994-07-08 | ||
PCT/SE1995/000816 WO1996001622A1 (en) | 1994-07-08 | 1995-07-03 | New oral pharmaceutical formulation containing magnesium salt of omeprazole |
Publications (2)
Publication Number | Publication Date |
---|---|
NO970036L true NO970036L (no) | 1997-01-06 |
NO970036D0 NO970036D0 (no) | 1997-01-06 |
Family
ID=20393105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO970036A NO970036D0 (no) | 1994-07-08 | 1997-01-06 | Nytt oralt, farmasöytisk preparat inneholdende magnesiumsalt av omeprazol |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0768872A1 (fi) |
KR (1) | KR970704426A (fi) |
BR (1) | BR9508261A (fi) |
CA (1) | CA2193681A1 (fi) |
CZ (1) | CZ379596A3 (fi) |
EE (1) | EE03378B1 (fi) |
FI (1) | FI970058A (fi) |
HU (1) | HUT78132A (fi) |
IS (1) | IS4398A (fi) |
MX (1) | MX9700152A (fi) |
NO (1) | NO970036D0 (fi) |
NZ (1) | NZ289958A (fi) |
PL (1) | PL181265B1 (fi) |
SK (1) | SK166096A3 (fi) |
WO (1) | WO1996001622A1 (fi) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9500478D0 (sv) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US5900258A (en) * | 1996-02-01 | 1999-05-04 | Zeolitics Inc. | Anti-bacterial compositions |
SI9700186B (sl) | 1997-07-14 | 2006-10-31 | Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. | Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin |
US6174548B1 (en) | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6096340A (en) | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
SE9704869D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulaton II |
SE9704870D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulation I |
US6733778B1 (en) | 1999-08-27 | 2004-05-11 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
SE9802973D0 (sv) | 1998-09-03 | 1998-09-03 | Astra Ab | Immediate release tablet |
US6316020B1 (en) * | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
AU3762801A (en) * | 2000-03-09 | 2001-09-17 | Andrew Ilchyshyn | Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin metronidazole and a gastrointestinal hydrogen pump inhibitor |
EP1133987A1 (en) * | 2000-03-09 | 2001-09-19 | Ian Whitcroft | Treatment of inflammatory dermatoses with combinations of erythromycin or clarythromycin, metronidazole and a hydrogen pump inhibitor |
CA2771725C (en) | 2002-10-16 | 2015-08-18 | Takeda Pharmaceutical Company Limited | Solid preparation comprising a non-toxic base and a proton pump inhibitor |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
EP1755566A2 (en) * | 2004-06-15 | 2007-02-28 | Teva Pharmaceutical Industries Ltd | Stable pharmaceutical formulations of benzimidazole compounds |
CN105106168B (zh) * | 2015-08-19 | 2018-03-06 | 德州德药制药有限公司 | 一种埃索美拉唑镁肠胶囊及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
JPH0768125B2 (ja) * | 1988-05-18 | 1995-07-26 | エーザイ株式会社 | 酸不安定化合物の内服用製剤 |
SE9302396D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | A novel compound form |
SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
-
1995
- 1995-07-03 MX MX9700152A patent/MX9700152A/es unknown
- 1995-07-03 HU HU9700039A patent/HUT78132A/hu unknown
- 1995-07-03 EE EE9700014A patent/EE03378B1/xx not_active IP Right Cessation
- 1995-07-03 WO PCT/SE1995/000816 patent/WO1996001622A1/en not_active Application Discontinuation
- 1995-07-03 BR BR9508261A patent/BR9508261A/pt not_active Application Discontinuation
- 1995-07-03 CA CA002193681A patent/CA2193681A1/en not_active Abandoned
- 1995-07-05 EP EP95926067A patent/EP0768872A1/en not_active Withdrawn
- 1995-07-05 NZ NZ289958A patent/NZ289958A/en unknown
- 1995-07-05 SK SK1660-96A patent/SK166096A3/sk unknown
- 1995-07-05 KR KR1019970700059A patent/KR970704426A/ko not_active Application Discontinuation
- 1995-07-05 CZ CZ963795A patent/CZ379596A3/cs unknown
- 1995-07-05 PL PL95318464A patent/PL181265B1/pl unknown
-
1996
- 1996-12-17 IS IS4398A patent/IS4398A/is unknown
-
1997
- 1997-01-06 NO NO970036A patent/NO970036D0/no not_active Application Discontinuation
- 1997-01-07 FI FI970058A patent/FI970058A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
SK166096A3 (en) | 1997-09-10 |
AU695723B2 (en) | 1998-08-20 |
IS4398A (is) | 1996-12-17 |
EE03378B1 (et) | 2001-04-16 |
NZ289958A (en) | 1998-09-24 |
MX9700152A (es) | 1997-04-30 |
KR970704426A (ko) | 1997-09-06 |
NO970036D0 (no) | 1997-01-06 |
EE9700014A (et) | 1997-06-16 |
WO1996001622A1 (en) | 1996-01-25 |
HUT78132A (hu) | 2000-06-28 |
FI970058A0 (fi) | 1997-01-07 |
WO1996001622A8 (en) | 1999-12-23 |
CZ379596A3 (en) | 1997-08-13 |
EP0768872A1 (en) | 1997-04-23 |
HU9700039D0 (en) | 1997-02-28 |
FI970058A (fi) | 1997-01-07 |
BR9508261A (pt) | 1997-12-23 |
CA2193681A1 (en) | 1996-01-25 |
AU2994795A (en) | 1996-02-09 |
PL181265B1 (pl) | 2001-06-29 |
PL318464A1 (en) | 1997-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO970036L (no) | Nytt oralt, farmasöytisk preparat inneholdende magnesiumsalt av omeprazol | |
CA2166483A1 (en) | New Pharmaceutical Formulation | |
DE69628444D1 (de) | Säurelabile omeprazol enthaltende pharmazeutische zusammensetzung und verfahren zu dessen herstellung | |
NO960837L (no) | Nye kuler for regulert frigjöring og et farmasöytisk preparat inneholdende slike | |
ATE427101T1 (de) | Orales system zur verabreichung von gepulsten dosen eines arzneistoffs | |
CA2147606A1 (en) | Stable Extended Release Oral Dosage Composition | |
CA2170647A1 (en) | Multiple unit tableted dosage form i | |
ATE244002T1 (de) | Pharmazeutische formulierung mit omeprazol | |
MX9604354A (es) | Nueva forma de dosis farmaceutica oral. | |
DE3880762D1 (de) | Orale, acetaminophen enthaltende zusammensetzung mit gesteuerter arzneistoff-freisetzung und verfahren zu ihrer herstellung. | |
GEP20033014B (en) | Enteric Coated Pharmaceutical Composition and Method of Manufacturing | |
NO863997L (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat | |
NO934836D0 (no) | Fremgangsmaate for fremstilling og anvendelse som medikament eller diagnostikum av 2,4-substituerte 5-(N-substituerte-sulfamoyl)-benzoylgu anidiner, og medikamenter som inneholder disse | |
DE3879536T2 (de) | Supraleitender keramischer film und verfahren zu dessen herstellung. | |
NO883986L (no) | Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter. | |
IT8721540A0 (it) | Composizioni farmaceutiche contenenti trapidil, loro procedimento di preparazione erelativo impiego terapeutico. | |
JO1821B1 (en) | New pharmaceutical product | |
TH19832EX (th) | สูตรผสมทางเภสัชกรรมชนิดใหม่ที่ประกอบรวมด้วยเกลือแมกนีเซียมของออเมพราโซลที่มีรูปแบบทางกายภาพชนิดใหม่และวิธีสำหรับการผลิตเกลือนี้ | |
NO930942L (no) | Nye 17-beta-oestradiolderivater, fremgangsmaater for deres fremstilling og legemiddel inneholdende disse forbindelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |